SELLAS Life Sciences Group, Inc. (SLS) Misses Q3 EPS by 35c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.33), $0.35 worse than the analyst estimate of $0.02.

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• What Delta’s report tells investors in American and United
• Wells Fargo previews Q2 midstream earnings, favors PAA and TRGP